EUVIMEDEUVIMED entdecken
Crossref

Severely Hyperammonemic Acute Liver Failure due to Paracetamol Overdose: The Impact of High-Intensity Continuous Renal Replacement Therapy

Anis Chaba, Stephen Joseph Warrillow, Caleb Fisher, Sofia Spano, Akinori Maeda, Atthaphong Phongphithakchai, Nuttapol Pattamin, Yukiko Hikasa, Nuanprae Kitisin, Scott Warming, Claire Michel, Glenn M Eastwood und 1 weitere

Blood Purification · 19.11.2024 · 54 (2) · 111-121

DOI: 10.1159/000542556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, online erschienen am 19.11.2024. Verfasst von Anis Chaba und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia, anis.chaba@hotmail.fr. Hauptthemen laut MEDLINE: Acetaminophen, Hyperammonemia, Liver Failure, Acute, Continuous Renal Replacement Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Paracetamol (acetaminophen)-induced acute liver failure (ALF) with severe hyperammonemia (ammonia >100 µmol⋅L−1) is a life-threatening condition. A strategy based on high-intensity continuous renal replacement therapy (CRRT) without early (up to day seven) transplantation may enable clinicians to safely identify which patients can recover and survive and which patients require transplantation.

Methods

We conducted a single-center, retrospective cohort study of patients with severely hyperammonemic paracetamol-induced ALF. The primary outcome was early transplant-free survival.

Results

We studied 84 patients (median age: 38; female sex: 79 [85%]) over a 12-year period (median ammonia level at ICU admission: 153 µmol⋅L−1; median peak aspartate aminotransferase (AST): 10,029 U⋅L−1; median lactate: 5.0 mmol⋅L−1; and median INR: 4.4) and 55 (65%) with King’s College criteria for transplantation. Overall, 87% received high-intensity CRRT (92% in 2020–2023). Median CRRT intensity was 54 mL⋅kg−1⋅hr−1 within the first 48 h and increased by 1.8 mL⋅kg−1⋅hr−1 per year during the study period (p = 0.002). Transplant-free survival to day 7 was 86% in 2011–2023 and 96% in 2020–2023. Overall, only 4 patients were transplanted and only 1 (4%) in 2020–2023. On multivariable Cox analysis, factors independently associated with failure to achieve day seven transplant-free survival were higher APACHE III score (HR = 1.05, 95% CI: 1.02–1.08), higher lactate (HR = 1.27, 95% CI: 1.12–1.44), and lower platelet count at ICU admission (HR = 0.85, 95% CI: 0.78–0.93) and the median effluent dose applied within the first 48 h of ICU admission (HR = 0.67, 95% CI: 0.46–0.98).

Conclusions

Early transplant-free survival is achievable in most patients with paracetamol-induced ALF and severe hyperammonemia with a treatment based on high-intensity CRRT. Such transplant-free survival increased over time together with increased CRRT dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenHyperammonemiaLiver Failure, AcuteContinuous Renal Replacement TherapyDrug OverdoseRenal Replacement TherapyHumansFemaleMaleRetrospective StudiesAdultMiddle AgedLiver TransplantationAnalgesics, Non-Narcotic

Stichwörter der Autor:innen

Acute liver failureContinuous renal replacement therapyHyperammonemiaParacetamol overdoseTransplant-free survival

Substanzen

AcetaminophenAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia, anis.chaba@hotmail.fr.
  • Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia, anis.chaba@hotmail.fr.
  • Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.
  • Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Medicine and Surgery, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Intensive Care, Peninsula Health, Melbourne, Victoria, Australia.

Zitieren

APA

Chaba, A., Warrillow, S. J., Fisher, C., Spano, S., Maeda, A., Phongphithakchai, A., Pattamin, N., Hikasa, Y., Kitisin, N., Warming, S., Michel, C., Eastwood, G. M., & Bellomo, R. (2024). Severely Hyperammonemic Acute Liver Failure due to Paracetamol Overdose: The Impact of High-Intensity Continuous Renal Replacement Therapy. Blood Purification, 54(2), 111-121. https://doi.org/10.1159/000542556

Vancouver

Chaba A, Warrillow SJ, Fisher C, Spano S, Maeda A, Phongphithakchai A, et al. Severely Hyperammonemic Acute Liver Failure due to Paracetamol Overdose: The Impact of High-Intensity Continuous Renal Replacement Therapy. Blood Purification. 2024;54(2):111-121. doi:10.1159/000542556

BibTeX
@article{Chaba2024,
  author = {Chaba, Anis and Warrillow, Stephen Joseph and Fisher, Caleb and Spano, Sofia and Maeda, Akinori and Phongphithakchai, Atthaphong and Pattamin, Nuttapol and Hikasa, Yukiko and Kitisin, Nuanprae and Warming, Scott and Michel, Claire and Eastwood, Glenn M and Bellomo, Rinaldo},
  title = {Severely Hyperammonemic Acute Liver Failure due to Paracetamol Overdose: The Impact of High-Intensity Continuous Renal Replacement Therapy},
  journal = {Blood Purification},
  year = {2024},
  volume = {54},
  number = {2},
  pages = {111--121},
  doi = {10.1159/000542556}
}
Kostenlos starten →